Amag Pharmaceuticals Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2020 to a ratio of 3.65, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Amag Pharmaceuticals Inc in Sep 30 2020 quarter, has decreased to 100 days, compared to 106 days, in the Jun 30 2020 quarter.

If we take a look into Healthcare sector 449 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2020 from 3142 to 3161.

What is Receivable Turnover Ratio?
What is Amag Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AMAG Receivables Turnover Ratio	(Sep 30 2020) III. Quarter	(Jun 30 2020) II. Quarter	(Mar 31 2020) I. Quarter	(Dec 31 2019) IV. Quarter	(Sep 30 2019) III. Quarter
Y / Y Receivable Change	-12.86 %	-21.73 %	27.78 %	24.97 %	-8.82 %
Y / Y Revenue Change	10.67 %	-32.46 %	-9.42 %	1.8 %	-31.17 %
Receivable Turnover Ratio (TTM)	3.65	3.44	3.55	3.88	4.08
AMAG's Total Ranking	# 3161	# 3142	# 2221	# 3138	# 3140
Accounts Receivable average collection period days	100	106	103	94	89
Seq. Receivable Change	3.85 %	-38.86 %	13.08 %	21.36 %	-6.73 %
Seq. Revenue Change	76.49 %	-23.17 %	-23.46 %	6.63 %	7.71 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 166
Healthcare Sector	# 450
Overall Market	# 3161

Receivable Turnover Ratio Statistics
High	Average	Low
11.04	6.28	3.43
(Dec 31 2013)		(Jun 30 2020)

AMAG Company Profile • Back to AMAG Efficiency Comparisons • Compare AMAG Receivables Turnover Ratio to its Competitors

Financial Statements
Amag Pharmaceuticals Inc 's Accounts Receivable	$ 68 Millions	Visit AMAG's Balance sheet
Amag Pharmaceuticals Inc 's Sales TTM	$ 304 Millions	Visit AMAG's Income Statement
Sources of AMAG's Revenues		Visit AMAG's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AMAG's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
AMAG's Growth Rates	AMAG's Roa	AMAG's Inventory Turnover Ratio	AMAG's Dividend Comparisons
AMAG's Profitability Ratios	AMAG's Roi	AMAG's Asset Turnover Ratio	AMAG's Dividend Growth
AMAG's Valuation Ratios	AMAG's Roe	AMAG's Financial Strength Ratios	AMAG's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2020, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2020	Receivable at quarter ending Sep 30 2020
Crispr Therapeutics Ag	12.20	$ 77.365 Millions	$ 6.340 Millions
Electrocore Inc	12.19	$ 3.243 Millions	$ 0.266 Millions
Sanara Medtech Inc	12.13	$ 17.118 Millions	$ 1.411 Millions
Lifeloc Technologies Inc	11.95	$ 6.981 Millions	$ 0.584 Millions
Teladoc Health Inc	11.95	$ 867.130 Millions	$ 72.593 Millions
Travere Therapeutics Inc	11.90	$ 194.026 Millions	$ 16.309 Millions
Prothena Corporation Public Limited Company	11.89	$ 0.749 Millions	$ 0.063 Millions
Integrated Biopharma Inc	11.59	$ 56.535 Millions	$ 4.878 Millions
Surmodics Inc	11.53	$ 94.864 Millions	$ 8.225 Millions
American Bio Medica Corporation	11.48	$ 4.249 Millions	$ 0.370 Millions
National Healthcare Corp	11.24	$ 1,022.272 Millions	$ 90.958 Millions
Harmony Biosciences Holdings inc	11.17	$ 45.609 Millions	$ 4.082 Millions
Dariohealth Corp	11.17	$ 7.294 Millions	$ 0.653 Millions
Protalix Biotherapeutics inc	11.13	$ 61.162 Millions	$ 5.496 Millions
Sunwin Stevia International Inc.	11.10	$ 23.513 Millions	$ 2.118 Millions
Insulet Corporation	11.10	$ 867.694 Millions	$ 78.200 Millions
Co diagnostics Inc	11.06	$ 47.516 Millions	$ 4.294 Millions
Dmk Pharmaceuticals Corporation	10.99	$ 14.998 Millions	$ 1.365 Millions
The Pennant Group Inc	10.84	$ 372.478 Millions	$ 34.364 Millions
Adamas Pharmaceuticals Inc	10.83	$ 69.799 Millions	$ 6.443 Millions
Intellia Therapeutics Inc	10.81	$ 62.335 Millions	$ 5.767 Millions
Scienture Holdings Inc	10.77	$ 16.824 Millions	$ 1.562 Millions
Capforce Inc	10.61	$ 3.683 Millions	$ 0.347 Millions
Allied Healthcare Products inc	10.53	$ 34.108 Millions	$ 3.239 Millions
Clearpoint Neuro Inc	10.52	$ 12.323 Millions	$ 1.172 Millions
Bicycle Therapeutics Plc	10.46	$ 11.823 Millions	$ 1.130 Millions
Strongbridge Biopharma plc	10.45	$ 28.111 Millions	$ 2.690 Millions
Acorda Therapeutics Inc	10.14	$ 165.303 Millions	$ 16.303 Millions
Zai Lab Limited	10.12	$ 46.849 Millions	$ 4.631 Millions
Insmed Inc	10.11	$ 168.706 Millions	$ 16.689 Millions

Date modified: 2026-09-08T15:10:04+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.